124 related articles for article (PubMed ID: 38741109)
1. Assessment of tumor hypoxia in spontaneous canine tumors after treatment with OMX, a novel H-NOX oxygen carrier, with [
Choen S; Kent MS; Loucks FA; Winger JA; Zwingenberger AL
BMC Vet Res; 2024 May; 20(1):196. PubMed ID: 38741109
[TBL] [Abstract][Full Text] [Related]
2. Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic
Thorwarth D; Welz S; Mönnich D; Pfannenberg C; Nikolaou K; Reimold M; La Fougère C; Reischl G; Mauz PS; Paulsen F; Alber M; Belka C; Zips D
J Nucl Med; 2019 Dec; 60(12):1698-1704. PubMed ID: 31076504
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
[TBL] [Abstract][Full Text] [Related]
4.
Yu W; Qiao F; Su X; Zhang D; Wang H; Jiang J; Xu H
Biomed Pharmacother; 2019 Nov; 119():109454. PubMed ID: 31526971
[TBL] [Abstract][Full Text] [Related]
5. Tumor Hypoxia Detected by
Tachibana I; Nishimura Y; Hanaoka K; Inada M; Fukuda K; Tatebe H; Ishikawa K; Nakamatsu K; Kanamori S; Hosono M
Anticancer Res; 2018 Mar; 38(3):1775-1781. PubMed ID: 29491116
[TBL] [Abstract][Full Text] [Related]
6. Kinetic Evaluation of the Hypoxia Radiotracers [
Choen S; Kent MS; Chaudhari AJ; Cherry SR; Krtolica A; Zwingenberger AL
Nucl Med Mol Imaging; 2023 Feb; 57(1):16-25. PubMed ID: 36643946
[TBL] [Abstract][Full Text] [Related]
7. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
Wei Y; Zhao W; Huang Y; Yu Q; Zhu S; Wang S; Zhao S; Hu X; Yu J; Yuan S
PLoS One; 2016; 11(6):e0157606. PubMed ID: 27322586
[TBL] [Abstract][Full Text] [Related]
9.
Grkovski M; Emmas SA; Carlin SD
J Nucl Med; 2017 Oct; 58(10):1567-1573. PubMed ID: 28360207
[TBL] [Abstract][Full Text] [Related]
10. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
[TBL] [Abstract][Full Text] [Related]
11. The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.
Okamoto S; Shiga T; Yasuda K; Watanabe S; Hirata K; Nishijima KI; Magota K; Kasai K; Onimaru R; Tuchiya K; Kuge Y; Shirato H; Tamaki N
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2147-2154. PubMed ID: 27251644
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Optimal Post-Injection Timing of Hypoxic Imaging with
Kawamura M; Yoshimura M; Shimizu Y; Sano K; Ishimori T; Nakamoto Y; Mizowaki T; Hiraoka M
Mol Imaging Biol; 2021 Aug; 23(4):597-603. PubMed ID: 33475945
[TBL] [Abstract][Full Text] [Related]
13. A Review of Hypoxia Imaging Using 18F-Fluoromisonidazole Positron Emission Tomography.
Hirata K; Watanabe S; Kitagawa Y; Kudo K
Methods Mol Biol; 2024; 2755():133-140. PubMed ID: 38319574
[TBL] [Abstract][Full Text] [Related]
14. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Tumor Hypoxia Metrics Derived from
Scarpelli ML; Healey DR; Fuentes A; Kodibagkar VD; Quarles CC
Tomography; 2020 Dec; 6(4):379-388. PubMed ID: 33364428
[No Abstract] [Full Text] [Related]
17. Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients.
Bourigault P; Skwarski M; Macpherson RE; Higgins GS; McGowan DR
Sci Rep; 2022 Dec; 12(1):21746. PubMed ID: 36526815
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [
Kelada OJ; Rockwell S; Zheng MQ; Huang Y; Liu Y; Booth CJ; Decker RH; Oelfke U; Carson RE; Carlson DJ
Mol Imaging Biol; 2017 Dec; 19(6):893-902. PubMed ID: 28409339
[TBL] [Abstract][Full Text] [Related]
19. 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
Muzi M; Peterson LM; O'Sullivan JN; Fink JR; Rajendran JG; McLaughlin LJ; Muzi JP; Mankoff DA; Krohn KA
J Nucl Med; 2015 Aug; 56(8):1223-8. PubMed ID: 26112020
[TBL] [Abstract][Full Text] [Related]
20. Measurement of tumor hypoxia in spontaneous canine sarcomas.
Bruehlmeier M; Kaser-Hotz B; Achermann R; Bley CR; Wergin M; Schubiger PA; Ametamey SM
Vet Radiol Ultrasound; 2005; 46(4):348-54. PubMed ID: 16229439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
